01—Abstract
Summary
Summary of the 8-K filed March 17, 2026. Cited figures are marked; the original filing is the authoritative source.
Docusign, Inc. reported financial results for the three months and fiscal year ended January 31, 2026, in a press release furnished as Exhibit 99.1 to this Form 8-K.
For the fourth quarter, total revenue was $836.9 milliona, up 8% year over year, and subscription revenue was $819.0 million, up 8%. GAAP net income per diluted share was $0.44 versus $0.39 a year earlier, and non-GAAP net income per diluted share was $1.01 versus $0.86. Free cash flow was $350.2 million versus $279.6 million, and repurchases of common stock were $269.1 million versus $161.7 million.
For fiscal 2026, total revenue was $3.2 billionb, up 8%, and Annual Recurring Revenue was $3,272 million, up 8.0% from $3,030 million. Intelligent Agreement Management (IAM) represented 10.8% of total ARR, compared with 2.3% a year earlier. Non-GAAP diluted EPS was $3.84 versus $3.55, and free cash flow for the year was $1,058.6 million (the filing's $1,058,562 thousand) versus $920.3 million.
Fiscal 2026 stock repurchases totaled $869.1 millionc. The Board authorized an additional $2.0 billion for the stock repurchase program, bringing total remaining authorization to up to $2.6 billion as of March 17, 2026.
Guidance calls for fiscal 2027 total revenue of $3,484 million to $3,496 milliond, an 8% midpoint increase, and an ARR growth rate of 8.25% to 8.75%. The company also said it will stop reporting and guiding to billings beginning in the first fiscal quarter of 2027.
02—Key points
Key Highlights
- Q4 FY2026 total revenue of $836.9 million, up 8% year over year; subscription revenue of $819.0 million, up 8%.
- Q4 GAAP net income per diluted share of $0.44 versus $0.39; non-GAAP diluted EPS of $1.01 versus $0.86.
- FY2026 ARR of $3,272 million, up 8.0%; IAM represented 10.8% of total ARR, up from 2.3% a year earlier.
- Board authorized an additional $2.0 billion stock repurchase; remaining authorization is up to $2.6 billion as of March 17, 2026.
- FY2027 guidance: total revenue of $3,484 million to $3,496 million (8% midpoint growth) and ARR growth of 8.25% to 8.75%.
- Free cash flow of $350.2 million in Q4 versus $279.6 million, and $1,058.6 million for the full year versus $920.3 million.
- Docusign will no longer report or guide to billings beginning in the first fiscal quarter of 2027; James Beer became Board Chair on February 1, 2026, and Brian Roberts joined the Board.
03—Questions
Frequently Asked Questions
How did Docusign perform in the fourth quarter of fiscal 2026?
Total revenue was $836.9 million, up 8% year over year, and subscription revenue was $819.0 million, up 8%. GAAP net income per diluted share was $0.44 versus $0.39, and non-GAAP diluted EPS was $1.01 versus $0.86. Operating cash flow was $377.2 million.
What is the new share repurchase authorization?
The Board authorized an increase of up to $2.0 billion to the existing stock repurchase program. As of March 17, 2026, total remaining authorization is up to $2.6 billion. The program has no minimum purchase commitment and no mandated end date, and it may be suspended or discontinued at any time.
What guidance did Docusign provide for fiscal 2027?
The company expects total revenue of $3,484 million to $3,496 million, an 8% midpoint year-over-year change, and ARR growth of 8.25% to 8.75%. Non-GAAP gross margin is expected at 81.5% to 82.0%, and non-GAAP operating margin at 30.0% to 30.5%.
How significant is the Intelligent Agreement Management (IAM) platform to results?
IAM represented 10.8% of total ARR as of January 31, 2026, up from 2.3% as of January 31, 2025. The CEO stated that customers using IAM represented over $350 million in ARR.
Are there any changes to how Docusign reports its metrics?
Beginning in the first fiscal quarter of 2027, Docusign will no longer report or guide to billings. The filing describes billings as a measure of upfront customer payments that it used to monitor working capital generated from those payments.
04—Continue